Eugene Quast - Natural Alternatives VP Sales
| NAII Stock | USD 4.57 0.06 1.30% |
Insider
Eugene Quast is VP Sales of Natural Alternatives International
| Age | 65 |
| Address | 1535 Faraday Avenue, Carlsbad, CA, United States, 92008 |
| Phone | 760 744 7700 |
| Web | https://www.nai-online.com |
Natural Alternatives Management Efficiency
The company has return on total asset (ROA) of (0.036) % which means that it has lost $0.036 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.0842) %, meaning that it created substantial loss on money invested by shareholders. Natural Alternatives' management efficiency ratios could be used to measure how well Natural Alternatives manages its routine affairs as well as how well it operates its assets and liabilities. The Natural Alternatives' current Return On Tangible Assets is estimated to increase to -0.04. The Natural Alternatives' current Return On Capital Employed is estimated to increase to -0.06. As of now, Natural Alternatives' Non Currrent Assets Other are increasing as compared to previous years. The Natural Alternatives' current Debt To Assets is estimated to increase to 0.11, while Total Current Assets are projected to decrease to under 36 M.Similar Executives
| Showing other executives | INSIDER Age | ||
| Carl Aure | Lifevantage | 50 | |
| Regina Wilson | FitLife Brands, Common | N/A | |
| Brendan Foley | McCormick Company Incorporated | 57 | |
| Jon Balousek | Central Garden Pet | 55 | |
| Mike McGoohan | Central Garden Pet | N/A | |
| Dave Fleming | Lifevantage | N/A | |
| Robert Conrad | McCormick Company Incorporated | N/A | |
| Jakob York | FitLife Brands, Common | 46 | |
| Jon Balousek | Central Garden Pet | 55 | |
| Randy Carper | McCormick Company Incorporated | N/A | |
| Lawrence Kurzius | McCormick Company Incorporated | 65 | |
| Dayton CPA | FitLife Brands, Common | 52 | |
| Sarah Piper | McCormick Company Incorporated | N/A | |
| Malcolm Swift | McCormick Company Incorporated | 63 | |
| Julie Boyster | Lifevantage | 38 | |
| Timothy Cofer | Central Garden Pet | 55 | |
| Matthew Cooley | Lifevantage | 51 | |
| Michael Smith | McCormick Company Incorporated | 58 | |
| Henry Zhou | Natures Sunshine Products | N/A | |
| Chris Taylor | Lifevantage | N/A | |
| Lisa Manzone | McCormick Company Incorporated | 58 | |
Management Performance
| Return On Equity | -0.0842 | ||||
| Return On Asset | -0.036 |
Natural Alternatives Leadership Team
Elected by the shareholders, the Natural Alternatives' board of directors comprises two types of representatives: Natural Alternatives inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Natural. The board's role is to monitor Natural Alternatives' management team and ensure that shareholders' interests are well served. Natural Alternatives' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Natural Alternatives' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Mark JD, Chairman CEO | ||
| Eugene Quast, VP Sales | ||
| Michael Fortin, Chief Officer | ||
| Shane Conti, Vice Sales | ||
| Kenneth Wolf, President, COO, Secretary and Treasurer |
Natural Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Natural Alternatives a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.0842 | ||||
| Return On Asset | -0.036 | ||||
| Profit Margin | (0.06) % | ||||
| Operating Margin | 0.08 % | ||||
| Current Valuation | 82.34 M | ||||
| Shares Outstanding | 6.2 M | ||||
| Shares Owned By Insiders | 21.24 % | ||||
| Shares Owned By Institutions | 30.85 % | ||||
| Number Of Shares Shorted | 9.72 K | ||||
| Price To Earning | 13.08 X |
Currently Active Assets on Macroaxis
When determining whether Natural Alternatives offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Natural Alternatives' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Natural Alternatives International Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Natural Alternatives International Stock:Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Natural Alternatives International. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Is Personal Care Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Natural Alternatives. If investors know Natural will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Natural Alternatives listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.741 | Earnings Share (1.44) | Revenue Per Share 19.383 | Quarterly Revenue Growth 0.265 | Return On Assets (0.04) |
The market value of Natural Alternatives is measured differently than its book value, which is the value of Natural that is recorded on the company's balance sheet. Investors also form their own opinion of Natural Alternatives' value that differs from its market value or its book value, called intrinsic value, which is Natural Alternatives' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Natural Alternatives' market value can be influenced by many factors that don't directly affect Natural Alternatives' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Natural Alternatives' value and its price as these two are different measures arrived at by different means. Investors typically determine if Natural Alternatives is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Natural Alternatives' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.